Aptevo Therapeutics Inc. (APVO) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Aptevo Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$1.30
−0.44% today
Market cap
$2M
Overall quality
36/100
Kronos AI 30-day
+115.0%
8 of 8 simulated paths end higher
Aptevo Therapeutics Inc. (APVO) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $2M. It trades at $1.30, down 0.44% today. Its overall quality score is 36 out of 100, ranked against the whole US market. 1 analysts' average target of $21.00 implies +1515.4% from today's price. Kronos AI's 30-day forecast is +115.0% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $21.00 |
| Low – high | $21.00 – $21.00 |
| Analysts | 1 |
| Upside to average | +1515.4% |
Kronos AI 30-day forecast
| Expected close | $2.75 (+115.0%) |
| Likely range | +82.3% … +160.9% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 34 |
| Solvency | 47 |
| Growth | 28 |
| Overall | 36 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.